News Release

Ashtray availability, signage may determine success of smoke-free legislation

Secondhand smoke levels more correlated with ashtray presence than signs banning smoking

Peer-Reviewed Publication

PLOS

Signs banning smoking may not have as much of an impact on secondhand smoke concentrations as the presence of ashtrays or ashtray equivalents, according to research published September 4 in the open access journal PLOS ONE by Constantine Vardavas from the Harvard School of Public Health and colleagues from other institutions.

The authors measured the success of a non-enforced, nationwide smoke-free legislation in Greece by testing levels of secondhand smoke before the ban and for two years afterward. Following the 2010 legislation, secondhand smoke concentrations dropped immediately, but gradually increased again in subsequent measurements. However, all measurements after the ban remained significantly lower than levels of secondhand smoke measured before the legislation.

They found that outdoor or indoor signs that banned smoking did not correlate with levels of secondhand smoke in areas where signs were posted. However, the presence of ashtrays, or ashtray equivalents, such as candleholders, was strongly associated with a higher concentration of secondhand smoke. Based on their results, the authors conclude "While the public may be supportive of smoke-free legislation, adherence may decline rapidly if enforcement is limited or non-existent. Moreover, enforcement agencies should also focus on the comprehensive removal of ashtray equivalents that could act as a cue for smoking within a venue."

###

Citation: Vardavas CI, Agaku I, Patelarou E, Anagnostopoulos N, Nakou C, et al. (2013) Ashtrays and Signage as Determinants of a Smoke-Free Legislation's Success. PLoS ONE 8(9): e72945. doi:10.1371/journal.pone.0072945

Financial Disclosure: Funding was provided by the George D. Behrakis Foundation through the HEART project (Hellenic Action for Research against Tobacco) awarded to the Harvard School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interest Statement: The authors have declared that no competing interests exist.

PLEASE LINK TO THE SCIENTIFIC ARTICLE IN ONLINE VERSIONS OF YOUR REPORT (URL goes live after the embargo ends): http://dx.plos.org/10.1371/journal.pone.0072945

Disclaimer: This press release refers to upcoming articles in PLOS ONE. The releases have been provided by the article authors and/or journal staff. Any opinions expressed in these are the personal views of the contributors, and do not necessarily represent the views or policies of PLOS. PLOS expressly disclaims any and all warranties and liability in connection with the information found in the release and article and your use of such information.

About PLOS ONE: PLOS ONE is the first journal of primary research from all areas of science to employ a combination of peer review and post-publication rating and commenting, to maximize the impact of every report it publishes. PLOS ONE is published by the Public Library of Science (PLOS), the open-access publisher whose goal is to make the world's scientific and medical literature a public resource.

All works published in PLOS ONE are Open Access. Everything is immediately available—to read, download, redistribute, include in databases and otherwise use—without cost to anyone, anywhere, subject only to the condition that the original authors and source are properly attributed. For more information about PLOS ONE relevant to journalists, bloggers and press officers, including details of our press release process and our embargo policy, see the everyONE blog at http://everyone.plos.org/media.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.